Window of opportunity to enhance EU regulatory systems wide open as EU pharma strategy prioritises stronger EU networks

19 January 2021

EU digital strategy requires investments in the digitalisation of Europe’s medicines regulatory agencies to succeed

15 January 2021

All routes to healthcare efficiency include biosimilar medicines

9 December 2020

EU Pharma Strategy: Success depends on access to Generic, Biosimilar and Value Added Medicines

25 November 2020

IGBA Launches First Global Biosimilars Week

16 November 2020

European Health Union – first step to greater EU solidarity in health crisis situations

11 November 2020

Joint EU-UK pharmaceutical industry response to Specialised Committee outcome

9 November 2020

Failure to launch: white paper explores the role of inappropriate use of IP in blocking access to generic and biosimilar medicines

5 November 2020

Open letter from Medicines for Europe Executive on the upcoming EU pharmaceutical strategy

20 October 2020

Statement from the President: Now or never: pragmatism & ambition needed in EU pharma strategy to deliver on Europe’s medicines manufacturing

7 October 2020

Berlin, 07 October 2020, speaking at ‘For a Healthy Europe’, […]